Delivery Order SPE2DB20D1100-SPE2DB25FA4B2

Award Date 2/3/25
Potential Completion Date 2/4/25
Potential Value $2.5K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, with an ID of SPE2DB20D1004|SPE2DB25FNEHX, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,504.69, is for the delivery of Jardiance 10 mg tablets. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November...
This federal contract award, with ID SPE2DB20D7059|SPE2DB24FQMJ8, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Jardiance 10 mg tablets. The contract has a firm fixed price of $1,151.42 and a completion date of September 10, 2024. Amerisourcebergen is the prime contractor, and there are no set-aside designations mentioned. This contract is likely part of a larger Indefinite Delivery Contract (IDC) between...
This federal contract award, with ID SPE2DB22D1106|SPE2DB25FDXL6, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract, valued at $1,612.03, is a Firm Fixed Price Delivery Order for the supply of the pharmaceutical product Jardiance 10 mg Tablet 90s. The contract has an ultimate completion date of February 5, 2025. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that plays a critical...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,456.64 Firm Fixed Price Delivery Order contract is for the supply of Jardiance 10 mg tablets. The contract has an ultimate completion date of October 21, 2024 and was awarded on October 18, 2024. This order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the...
This federal contract award was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The $20,475.63 firm fixed price delivery order is for the supply of Jardiance 10 mg tablets. The award has an ultimate completion date of February 28, 2024. Amerisourcebergen Drug Corp, a for-profit pharmaceutical distributor, is the awardee. This contract award is associated with a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that...
This federal contract award was issued to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) for the delivery of Jardiance 10 mg tablets. The contract, valued at $141,524.90, is a firm fixed-price delivery order contract with a completion date of December 4, 2024. The contract is not designated with a set-aside requirement, indicating open competition. Amerisourcebergen holds a larger Indefinite Delivery...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Jardiance 25 mg tablets. The contract has a ceiling value of $4,648.98 and an ultimate completion date of May 16, 2024. It is a Firm Fixed Price Delivery Order contract, without any set-aside designation. Amerisourcebergen Drug Corp is the prime contractor on this award, which is part of a larger Indefinite Delivery Contract (IDC)...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Jardiance 25 mg tablets. The contract has a ceiling value of $2,387.90 and a performance period ending on July 1, 2024. This appears to be a delivery order under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with DLA Troop Support Medical. The IDC provides a mechanism for the...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Jardiance 25 mg tablets. The contract has a ceiling value of $9,320.87 and was awarded as a firm-fixed price delivery order with an ultimate completion date of August 28, 2024. The contract is not designated as a set-aside. This award is likely part of a larger Indefinite Delivery Contract (IDC) vehicle between Amerisourcebergen and...
This is a federal contract award by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of Jardiance 25 mg tablets. The contract has a ceiling value of $6,037.29 and an ultimate completion date of October 15, 2024. This contract is a delivery order under a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999 with the DLA Troop Support Medical, which provides a comprehensive range of medical commodities to...
  • SPE2DB20D1100
    Indefinite Delivery Contract
  • SPE2DB20D1100-SPE2DB25FA4B2
    Delivery Order

This federal contract award, with the ID SPE2DB20D1100|SPE2DB25FA4B2, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp for the delivery of Jardiance 10 mg tablets. The contract has a ceiling value of $2,461.53 and a completion date of February 4, 2025. The contract is a Firm Fixed Price Delivery Order and does not have a set-aside designation, indicating it was competitively awarded. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that plays a critical role in supplying medical products to federal government agencies, including the military healthcare system. The company holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.

Generated 5/5/25, 9:54 AM